MENICHI, G.;NACIRI, J.;KOKEL, B.;HUBERT-HABART, M., HETEROCYCLES, 1984, 22, N 9, 2013-2017
作者:MENICHI, G.、NACIRI, J.、KOKEL, B.、HUBERT-HABART, M.
DOI:——
日期:——
Structure–Activity Relationship Studies of Ethyl 2-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate: An Inhibitor of AP-1 and NF-κB Mediated Gene Expression
作者:Moorthy S.S. Palanki、Leah M. Gayo-Fung、Graziella I. Shevlin、Paul Erdman、Mark Sato、Mark Goldman、Lynn J. Ransone、Cheryl Spooner
DOI:10.1016/s0960-894x(02)00517-6
日期:2002.9
Several analogues of ethyl 2-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate (1) were synthesized and tested as inhibitors of AP-1 and NF-kappaB mediated transcriptional activation in Jurkat T cells. From our SAR work, ethyl 2-[(3-methyl-2,5-dioxo(3-pyrrolinyl))-N-methylamino]-4-(trifluoromethyl)-pyrimidine-5-carboxylate was identified as a novel and potent inhibitor. (C) 2002 Elsevier Science Ltd. All rights reserved.
Ring contraction of a 5-acetylpyrimidine into pyrazoles by the action of substituted hydrazines in acidic medium
M.G.B.G. pointed out to a new possibility of ring contraction of pyrimidines into pyrazoles. We attempted therefore to study the possibility of extending this transformation to other substituted hydrazines and to define more accurately the conditions of this reaction as well as to prepare new potential anticancer drugs.